The expression and putative role of chemokines during infection with Leishmania major in mice were investigated. CCL5 expression correlates with resistance, and blockade of CCL5 rendered mice more susceptible to infection. CCL5 is part of the cascade of events leading to efficient parasite control in L. major infection.
nificantly greater quantities of CCL5 than BALB/c mice at weeks 4 and 6 of infection. The decrease in CCL5 levels observed in C57BL/6 mice coincided with the resolution of infection and inflammation at the site of infection (data not shown).
Further studies were performed to verify whether CCL2 and CCL5 were markers of susceptibility and resistance, as suggested for BALB/c and C57BL/6 mice. Hence, we infected susceptible interleukin-12 knockout (IL-12 Ϫ/Ϫ ) and gamma interferon knockout (IFN-␥ Ϫ/Ϫ ) C57BL/6 mice and resistant IL-4 Ϫ/Ϫ BALB/c mice (6, 10, 23) with L. major ( Fig. 2A ). CCL5 and CCL2 expression was determined by real-time RT-PCR and ELISA. CCL5 protein and mRNA expression levels correlated well. As shown in Fig. 2 , CCL5 expression at week 6 of infection was higher in the resistant (IL-4 Ϫ/Ϫ ) and lower in the susceptible (IL-12 Ϫ/Ϫ and IFN-␥ Ϫ/Ϫ ) mouse strains. Conversely, there was no correlation between expression of CCL2 protein and susceptibility or resistance to infection ( Fig. 2B and C). Moreover, there was no equivalence between CCL2 mRNA and protein expression levels.
The results described above suggest that CCL5 may be relevant to resistance against L. major infection. To verify this possibility, C57BL/6 mice were treated daily subcutaneously with Met-RANTES (10 g/mouse; kindly provided by A. E. Proudfoot, Serono Pharmaceuticals, Geneva, Switzerland), a functional antagonist of CCR1 and CCR5 (1, 7, 12) . Treatment started at week 2 of infection, when no significant increase in CCL5 mRNA expression was observed. Treatment with Met-RANTES led to a transitory increase in lesion size (Fig. 3A) . Mice were sacrificed at weeks 3 and 5 after treatment. At 3 weeks, there was an increase in IL-4 mRNA but no change in IFN-␥ expression in lesions (Fig. 3B) . Met-RANTES also promoted an impressive down-regulation of the production of IFN-␥ in draining lymph nodes, whereas IL-4 production was unchanged (Table 1) . Tissue parasitism in these lesions was evaluated by PCR (19) and was higher in the Met-RANTEStreated group at week 3 of treatment (Fig. 3C) , which was further confirmed in another experiment by serial dilution were infected with L. major and sacrificed at 1 day, 2 days, 2 weeks, and 6 weeks postinfection, and the hind infected footpad was used in assays of mRNA expression by RT-PCR and ELISA. Representative gels are shown. (B) Densitometric analysis was performed, and quantification was normalized to the levels of hypoxanthine phosphoribosyltransferase (HPRT) expression. Results are expressed as n-fold increases over results with noninfected (NI) control animals. (C) ELISA for detection of chemokines at the site of infection was performed at 1 and 2 days and at 2, 4, 6, and 8 weeks postinfection. Briefly, footpad proteins were extracted at 50 mg of tissue/100 l of phosphate-buffered saline to which 0.4 M NaCl, 0.05% Tween 20, and protease inhibitors (0.1 mM phenylmethylsulfonyl fluoride, 0.1 mM benzethonium chloride, 10 mM EDTA, and 20 KI aprotinin A/100 ml) were added. The samples were centrifuged for 10 min at 3,000 ϫ g, and the supernatant was immediately used for ELISAs. ELISA plates were coated overnight with sheep anti-mouse CCL2 (Pharmingen, San Diego, Calif.) or CCL5 (RD Systems, Minneapolis, Minn.), and ELISAs were performed as recommended by the manufacturer. The anti-CCL2 assay had a sensitivity of 16 pg/ml, and the anti-CCL5 assay had a sensitivity of 32 pg/ml. * and **, statistical differences (P Ͻ 0.05) between results for C57BL/6 and BALB/c for each point, determined by Student's t test. In panel B, each point represents the mean (Ϯstandard error [SE] ) for at least three mice per time point of one experiment of three performed. mRNA expression) following treatment with the drug. All results were confirmed using anti-CCL5 antiserum (gift from Nicholas Lukacs, University of Michigan Medical School, Ann Arbor), which also rendered mice more susceptible and showing larger lesions, eightfold more parasites/mg of tissue by limiting dilution, and lower IFN-␥ production than mice treated with control antibody and no alteration of IL-4 production by draining lymph nodes (data not shown).
Resistance to leishmaniasis is highly dependent on a Th1 response (18) . CCL5 up-regulates IL-12 (1), IFN-␥ (8), and migration of Th1 cells, particularly memory T cells (24) . Treatment with Met-RANTES or anti-CCL5 rendered C57BL/6 animals more susceptible to L. major and skewed the immune response from type 1 to type 2 by diminishing IFN-␥ production by draining lymph nodes and increasing IL-4 mRNA expression in lesions. Such skewing may explain why the treatment with Met-RANTES or anti-CCL5 promoted increased susceptibility to infection. However, CCR5-deficient mice were not more susceptible to L. major than their wild-type counterparts (our unpublished data and reference 20), and CCR1-deficient mice were more resistant than wild-type mice (17) . The explanation for such differences is not immediately apparent. Possibly, a blockade of the action of CCL5 on CCR1 and CCR5 simultaneously is necessary for an increase in susceptibility to infection. The expression of CCL2 did not correlate with resistance or susceptibility to infection. This finding is in agreement with those of other studies that found no correlation between CCL2 and susceptibility to leishmaniasis (4, 15, 16, 22, 25) . These data challenge the importance of CCL2 in determining susceptibility to L. major in models other than that of the wild-type BALB/c mouse. It is likely that the concerted and timely actions of several chemokines and chemokine receptors are necessary to control Leishmania infection, and their roles are just beginning to be understood.
Our results demonstrate a correlation between CCL5 expression and resistance to infection. Altogether, these data support a role for CCL5 in the cascade of events leading to parasite control during L. major infection. 
